European pharmaceutical research and development. Could a public infrastructure overcome market failures?
Massimo Florio and
Chiara Pancotti ()
Additional contact information
Chiara Pancotti: CSIL Centre for Industrial Studies, https://www.csilmilano.com/team/chiara-pancotti/
Working Papers from CSIL Centre for Industrial Studies
Abstract:
With a focus on research and development in innovative medicines, this working paper discusses a new European approach to pharmaceutical policy. After examining the European pharmaceutical sector's features, and the strengths and weaknesses of the current research and business model, the study explores the need for and the concept of a European infrastructure with a long-term transboundary mission. Any European medicines infrastructure should focus on threats and research and development areas underinvested under the current business model. More specifically, the study uses an extensive literature review to investigate the feasibility of different options in terms of the scope of the mission and legal, organisational and financial arrangements for establishing such a European infrastructure. Based on their research, the authors present a range of policy options. The most ambitious of these considers a Europe-wide public infrastructure with budgetary autonomy and home-grown research and development capacity. This organisation would be tasked with building a portfolio of new medicines and related biomedical technologies up to the delivery stage over 30 years, in partnership with third-party research centres at the national or European level and with companies. It would be the world's most important global player in biomedical innovation
Keywords: coronavirus disease; epidemic; medical research; pharmaceutical expenses; pharmaceutical industry; pharmacy; public health; technology assessment (search for similar items in EconPapers)
JEL-codes: D61 H42 (search for similar items in EconPapers)
Pages: 25 pages
Date: 2022-09-01
New Economics Papers: this item is included in nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.csilmilano.com/docs/WP2022_02.pdf (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:mst:wpaper:202202
Access Statistics for this paper
More papers in Working Papers from CSIL Centre for Industrial Studies Contact information at EDIRC.
Bibliographic data for series maintained by Marinella Manghina ().